GT Biopharma Inc. (GTBP) Announces Corporate Update Conference Call
GT Biopharma Inc. (GTBP), a targeted immunotherapies company with close to market treatments for Central Nervous System (CNS) diseases (neurology and pain), will hold a conference call, hosted by www.biotechstocks.com, to discuss advancements made with the targeted immunotherapies currently in FDA clinical trials and its newly acquired CNS drugs.
PotNetwork Holdings (POTN) Ahead Of Earnings
So far this year, (POTN) has generated more than $5 million in revenue and the company has recorded very strong growth on a month-over-month basis. If we are speaking to growth, it’s hard to miss the fact that in the month of July, the company generated $1.46m in revenue alone, when some companies struggle to do the same revenue in an entire year! Now we’re looking into (POTN) ahead of their next earning’s report, could this be the next catalyst for a continuation of the uptrend (POTN) is seeing right now?
(LBUY) has been dubbed “The Priceline of Pot” and a “Game Changer” for the Marijuana Industry:
Future Farm Technologies Inc. (FFRMF) Bringing Augmented Reality to the Cannabis Industry
Future Farm Technologies Inc. (the “Company” or “Future Farm”) ( CSE : FFT ) ( OTCQB : FFRMF ) is pleased to announce that it has signed a license agreement with AR E1, LLC (“ARE1″) wherein the Company has acquired the exclusive right to use AR E1’s patented technology in the cannabis industry. Future Farm and AR E1 will work together to merge augmented reality (AR) and ad-tech with the cannabis industry through the CannaCube Live™ platform. This transaction brings both an impressive portfolio of intellectual property as well as a very experienced development team whom have created over 300 AR apps for major clients like: Disney, Coca-Cola, Colgate, Toyota, Kellogg, AT&T, General Motors, Ford, Pirelli, FedEx, Chevrolet, as well as many other blue chip clients.